Neuropathic Pain Market by Drug Class (Tricyclic Antidepressants, Opioids, Capsaicin Cream, Steroids, and Others), Indication (Diabetic Neuropathy, Spinal Stenosis, and Chemotherapy-induced Peripheral Neuropathy), and Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, and Others): Global Opportunity Analysis and Industry Forecast, 2018–2025
|
A05082
|
Pages: NA
|
May 2020 |
476 Views
|
|
|
|
Author(s) :
NA
|
Tables: NA
|
Charts: NA
|
Formats*:
|
|
Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. This pain is associated with abnormal sensations called dysesthesia or pain from normally non-painful stimuli. It may have continuous and episodic components. The latter resemble stabbings or electric shocks. It often causes nerve damage or malfunctioning of nervous system. The impact of nerve damage can cause change in nerve function both at the site of the injury and areas around it. One example of neuropathic pain is called phantom limb syndrome, which is a rare condition. It occurs when an arm or a leg has been removed due to illness or injury, but the brain still gets pain messages from the nerves that carries impulses from the missing limb. These nerves misfire and cause pain.
Diabetes is the most common indication for neuropathic pain. Increase in geriatric population across the globe is expected to drive the demand for neuropathic pain management services, as the prevalence of painful diabetic neuropathy is 16% in the global elderly population suffering from diabetes. Rise in prevalence of diabetes & cancer, approval of novel treatment options for neuropathic pain, surge in number of pain management centers, and increase in demand for treatment of neuropathic pain are the major factors expected to drive the growth of the global neuropathic pain market. Other trends driving the market growth rapidly. Moreover, increase in demand for neuropathic pain market drugs and introduction of latest products for the treatment of neuropathic pain boost the growth of the market. Well-established healthcare infrastructure and increase in reimbursements are further expected to propel the growth of the global neuropathic pain market. Furthermore, pharmaceutical companies are focusing on development of improved drugs to cater to the unmet needs of patients suffering from neuropathic pain, which supplements the market growth. However, severe side effects of opioids and steroids and rapid rise in costs of branded drugs are some of the factors likely to restrain the growth of the global neuropathic pain market during the forecast period.
The global neuropathic pain market is segmented based on drug class, indication, distribution channel, and region. Depending on drug class, the market is divided into tricyclic antidepressants, opioids, capsaicin cream, and steroids. By indication, it is categorized into diabetic neuropathy, spinal stenosis, and chemotherapy-induced peripheral neuropathy. On the basis of distribution channel, it is classified into retail pharmacies, hospital pharmacies, and online pharmacies. Region wise, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The market is highly competitive in nature, with major competitor focused on creating awareness regarding the neuropathic pain industry. Major players in the market host exhibition and seminars to display and promote the use of effective medicines for diverse medical applications. The prominent players in the market have adopted various strategies for development, such as product innovation, product launches & approvals, and investment in R&D for advancements. Top leading neuropathic pain medicine manufacturer are Eli Lilly and Company, Astellas Pharma Inc., Biogen Inc., Baxter Healthcare Corporation, Pfizer, Inc., Sanofi S.A, Abbott Laboratories, AstraZeneca, Johnson & Johnson Services Inc., and GlaxoSmithKline Plc.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a detailed quantitative analysis of the current neuropathic pain market trends and neuropathic pain market forecast estimations from 2018 to 2025, which assists to identify the prevailing neuropathic pain market opportunities.
- An in-depth neuropathic pain market analysis includes analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
- A comprehensive analysis of the factors that drive and restrain the growth of the global neuropathic pain market is provided.
- Region-wise and country-wise neuropathic pain market conditions are comprehensively analyzed in this report.
- The projections in this report are made by analyzing the current neuropathic pain market trends and future market potential from 2018 to 2025 in terms of value.
- An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
- Key market players within the neuropathic pain market are profiled in this report and their strategies are analyzed thoroughly, which helps to understand the competitive outlook of global neuropathic pain market.
KEY MARKET SEGMENTS
By Drug Class
- Tricyclic Antidepressants
- Opioids
- Capsaicin Cream
- Steroids
- Others
By Indication
- Diabetic Neuropathy
- Spinal Stenosis
- Chemotherapy-induced Peripheral Neuropathy
By Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Rest of Europe
- Asia-Pacific
- Australia
- Japan
- India
- China
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
- Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through well audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of marketplace
With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.
Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, web-casts and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast
Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develops analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth and forecasts
Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:
- Chief executives and VPs of leading corporations specific to industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)
Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
REQUEST TOC/SAMPLE
Purchase Full Report of
Neuropathic Pain Market
- Online Only
-
$3,456$3,110 - Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Data Pack
-
$3,840$3,456 - Restricted to one authorized user
- One print only
- Available in
Excel - Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Single User
-
$5,370$4,833 - Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Five Users
-
$6,450$5,805 - Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
-
Enterprise
License/PDF -
$8,995$8,096 - Unlimited
within
company/enterprise - Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Library Membership
- $0.00
- Published Content
E-access - Company Profiles
E-access - Newly Added Content Access
- 10 PDF
Downloads - 5 Excel Data
Pack Downloads - 250 Company Profiles PDF Downloads
-
Start reading.
Buy Now
This title and over 12,000+ are available on the Avenue Library. Subscription @ $699 T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.